Intravenous Ferric Carboxymaltose (Ferinject®) With or Without Erythropoietin in Patients Undergoing Orthopaedic Surgery

This study has been terminated.
(Not being able to recuit sufficient patients due to a lack of complience)
Sponsor:
Collaborator:
Vifor Inc.
Information provided by (Responsible Party):
University of Zurich
ClinicalTrials.gov Identifier:
NCT00706667
First received: June 25, 2008
Last updated: June 19, 2013
Last verified: June 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2012
  Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)